These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 10331992)

  • 1. Direct and indirect antigen recognition: the pathways to allograft immune rejection.
    Benichou G
    Front Biosci; 1999 May; 4():D476-80. PubMed ID: 10331992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of alloreactivity to MHC-derived peptides and transplantation tolerance.
    Benichou G; Kant CD; Madsen J; Tocco G
    Front Biosci; 2007 May; 12():4239-47. PubMed ID: 17485370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathways of allorecognition: implications for transplantation tolerance.
    Game DS; Lechler RI
    Transpl Immunol; 2002 Aug; 10(2-3):101-8. PubMed ID: 12216939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indirect T cell recognition in allograft rejection.
    Bradley JA
    Int Rev Immunol; 1996; 13(3):245-55. PubMed ID: 8782745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the contribution that direct allorecognition makes to the progression of chronic cardiac transplant rejection in humans.
    Hornick PI; Mason PD; Yacoub MH; Rose ML; Batchelor R; Lechler RI
    Circulation; 1998 Apr; 97(13):1257-63. PubMed ID: 9570195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New strategies for early diagnosis of heart allograft rejection.
    Tugulea S; Ciubotariu R; Colovai AI; Liu Z; Itescu S; Schulman LL; Fisher PE; Hardy MA; Rose EA; Michler RE; Cortesini R; Suciu-Foca N
    Transplantation; 1997 Sep; 64(6):842-7. PubMed ID: 9326408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell Allorecognition Pathways in Solid Organ Transplantation.
    Siu JHY; Surendrakumar V; Richards JA; Pettigrew GJ
    Front Immunol; 2018; 9():2548. PubMed ID: 30455697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allograft survival following immunization with membrane-bound or soluble peptide MHC class I donor antigens: factors relevant for the induction of rejection by indirect recognition.
    Terness P; Dufter C; Otto G; Opelz G
    Transpl Int; 1996; 9(1):2-8. PubMed ID: 8748404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice.
    Benichou G; Valujskikh A; Heeger PS
    J Immunol; 1999 Jan; 162(1):352-8. PubMed ID: 9886406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of autoimmunity after skin graft rejection via an indirect alloresponse.
    Valujskikh A; Fedoseyeva E; Benichou G; Heeger PS
    Transplantation; 2002 Apr; 73(7):1130-7. PubMed ID: 11965045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression.
    Gallon L; Watschinger B; Murphy B; Akalin E; Sayegh MH; Carpenter CB
    Transplantation; 1995 Feb; 59(4):612-6. PubMed ID: 7878766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mosaic of immunosuppressive drugs.
    Masri MA
    Mol Immunol; 2003 Jul; 39(17-18):1073-7. PubMed ID: 12835079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II.
    Pietra BA; Wiseman A; Bolwerk A; Rizeq M; Gill RG
    J Clin Invest; 2000 Oct; 106(8):1003-10. PubMed ID: 11032860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of indirect allorecognition in allograft rejection.
    Sayegh MH; Carpenter CB
    Int Rev Immunol; 1996; 13(3):221-9. PubMed ID: 8782743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of autoimmunity after allotransplantation.
    Benichou G; Alessandrini A; Charrad RS; Wilkes DS
    Front Biosci; 2007 May; 12():4362-9. PubMed ID: 17485380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indirect T-cell allorecognition: perspectives for peptide-based therapy in transplantation.
    Benichou G; Tam RC; Soares LR; Fedoseyeva EV
    Immunol Today; 1997 Feb; 18(2):67-71. PubMed ID: 9057356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of the indirect pathway of allorecognition in clinical transplantation.
    Gökmen MR; Lombardi G; Lechler RI
    Curr Opin Immunol; 2008 Oct; 20(5):568-74. PubMed ID: 18655831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of the role of professional versus semiprofessional or nonprofessional antigen presenting cells in the rejection of vascularized organ allografts.
    Sundstrom JB; Ansari AA
    Transpl Immunol; 1995 Dec; 3(4):273-89. PubMed ID: 8665146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited T cell response to donor MHC peptides during allograft rejection. Implications for selective immune therapy in transplantation.
    Benichou G; Fedoseyeva E; Lehmann PV; Olson CA; Geysen HM; McMillan M; Sercarz EE
    J Immunol; 1994 Aug; 153(3):938-45. PubMed ID: 7517977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The basis of immunogenicity of endocrine allografts.
    Nicolls MR; Coulombe M; Gill RG
    Crit Rev Immunol; 2001; 21(1-3):87-101. PubMed ID: 11642616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.